|
4092.0: Tuesday, November 9, 2004: 12:30 PM-2:00 PM | |||
Poster | |||
| |||
Learning Objectives: See individual abstracts. | |||
"I just sit and stay in my apartment": Women drug users trying to stay clean Jennifer Fuld, MA, PhD Candidate, Maureen Miller, PhD | |||
Measuring performance: Substance abuse treatment program outcomes Donna Atkinson, PhD, Kevin P. Mulvey, PHD, James W. Luckey, PhD, Maurice Wilson, PhD, Deepa Avula | |||
Perceptions of Narcotics and Alcoholics Anonymous among polysubstance users newly admitted to outpatient treatment Alexandre Laudet, PhD, Virginia Stanick, PhD, CSW | |||
Impact of perceived and actual support on substance abuse treatment outcome among female Native Americans in substance abuse treatment Jenny Chong, PhD, Darlene Lopez, MS | |||
Substance abuse treatment admissions in the United States 1992-2001: Analysis using the National Treatment Episode Data Set Leigh A. Henderson, PhD, Christian Evans, MA MDiv, Lev S. Sverdlov, MD PhD, Deborah Trunzo | |||
Clinical case management and welfare to work: For whom does it make a difference? Neil Pessin, PhD, David C. Lindy, MD, Tara Mendizabal, MS | |||
Motivationally-enhanced group counseling for substance users in a soup kitchen: A randomized clinical trial Andrew Rosenblum, PhD, Stephen Magura, CSW, PhD, Deborah J. Kayman, CSW, PhD, Cherry B. Gordon, MA, CASAC, Chunki Fong, MS, Rita Morales | |||
Predictors of abstinence at 9-month post admission from substance abuse treatment: Results from a national study Kazi A Ahmed, PhD, Careema Yusuf, MPH, Roshan Hussain, MPH, John Cacciola, PhD | |||
Evaluating cost utilization after treatment for substance abuse: An examination of growth mixtures William Fals-Stewart, PhD, Brian T. Yates, PhD, Keith C. Klostermann, PhD | |||
Assessing the costs of delivering group-versus individual-based treatment to substance-abusing patients: Administrative versus societal perspectives Keith C. Klostermann, PhD, Brian T. Yates, PhD, William Fals-Stewart, PhD | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Organized by: | Alcohol, Tobacco, and Other Drugs |